COVID-19: WHO suspends trial of hydroxychloroquine over safety concerns

Premium Times Nigeria

25 May 2020 0 shares 1 views

COVID-19: WHO suspends trial of hydroxychloroquine over safety concerns

Premium Times Nigeria

Published 25 May 2020

WHO also said this decision only applies to the use of the hydroxychloroquine and chloroquine in COVID-19 patients.

The post COVID-19: WHO suspends trial of hydroxychloroquine over safety concerns appeared first on Premium Times Nigeria.

Full Article

Germany pauses anti-malaria drug study for COVID-19: Spiegel

Reuters India 29 May 2020

A university in Germany has suspended a clinical study using the anti-malaria drug hydroxychloroquine for COVID-19, Spiegel Online..

France bans controversial drug to treat COVID-19
Brisbane Times 27 May 2020
WHO expects hydroxychloroquine safety findings by mid-June
Reuters India 26 May 2020
WHO says hydroxychloroquine safety findings expected by mid-June
Reuters India 26 May 2020
Coronavirus outbreak: WHO warns of COVID-19 'second peak' as lockdowns ease
Mid-Day 26 May 2020

More coverage

WHO Suspends Hydroxychloroquine Trial Over Safety Concerns

Newsy 25 May 2020

Watch VideoThe World Health Organization said it's going to temporarily suspend testing on hydroxychloroquine as a potential..

WHO pauses trial of hydroxychloroquine, once touted by Trump as a ‘game changer,’ over safety concerns
Seattle Times 26 May 2020
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
Reuters India 26 May 2020
WHO Halts Hydroxychloroquine Trial Over Safety Concerns
NPR 25 May 2020
UN virus therapy trial pauses hydroxychloroquine testing
SeattlePI.com 25 May 2020

COVID-19: WHO suspends trial of hydroxychloroquine over safety concerns

COVID-19: WHO suspends trial of hydroxychloroquine over safety concerns

You might like

Related news coverage

Germany pauses anti-malaria drug study for COVID-19: Spiegel

Advertisement

More coverage

WHO Suspends Hydroxychloroquine Trial Over Safety Concerns